Wesolowski, Gregg
38  Ergebnisse:
Personensuche X
?
1

Lead optimization of cathepsin K inhibitors for the treatme..:

Ginnetti, Anthony T. ; Paone, Daniel V. ; Nanda, Kausik K....
Bioorganic & Medicinal Chemistry Letters.  74 (2022)  - p. 128927 , 2022
 
?
2

Preclinical evaluation of [11C]L‐235 as a radioligand for P..:

Bennacef, Idriss ; Rubins, Daniel ; Riffel, Kerry...
Journal of Labelled Compounds and Radiopharmaceuticals.  64 (2020)  4 - p. 159-167 , 2020
 
?
 
?
4

Applicability of in vitro-in vivo translation of cathepsin ..:

Ma, Bennett ; Luo, Bin ; Euler, Danielle H....
Naunyn-Schmiedeberg's Archives of Pharmacology.  390 (2017)  4 - p. 435-441 , 2017
 
?
5

Determination of in Vivo Enzyme Occupancy Utilizing Inhibit..:

Murphy, Dennis J. ; Ou, Yangsi ; Euler, Danielle H....
Journal of the American Chemical Society.  137 (2015)  35 - p. 11230-11233 , 2015
 
?
8

Difluoroethylamines as an amide isostere in inhibitors of c..:

Isabel, Elise ; Mellon, Christophe ; Boyd, Michael J....
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  3 - p. 920-923 , 2011
 
?
9

The discovery of MK-0674, an orally bioavailable cathepsin ..:

Isabel, Elise ; Bateman, Kevin P. ; Chauret, Nathalie...
Bioorganic & Medicinal Chemistry Letters.  20 (2010)  3 - p. 887-892 , 2010
 
?
 
?
12

The discovery of odanacatib (MK-0822), a selective inhibito..:

Gauthier, Jacques Yves ; Chauret, Nathalie ; Cromlish, Wanda...
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  3 - p. 923-928 , 2008
 
?
13

β-Substituted cyclohexanecarboxamide cathepsin K inhibitors..:

Robichaud, Joël ; Bayly, Christopher I. ; Black, W. Cameron...
Bioorganic & Medicinal Chemistry Letters.  17 (2007)  11 - p. 3146-3151 , 2007
 
?
15

Design and synthesis of tetracyclic nonpeptidic biaryl nitr..:

Setti, Eduardo L. ; Venkatraman, Shankar ; Palmer, James T....
Bioorganic & Medicinal Chemistry Letters.  16 (2006)  16 - p. 4296-4299 , 2006
 
1-15